Abstract
OBJECTIVE: This case report describes and discusses the therapeutic potential of nisin ZP as adjunctive therapy in patients with oral squamous cell carcinoma (OSCC). CASE REPORT: A 43-year-old Asian male with OSCC initiated treatment with Paclitaxel and Cisplatin chemotherapy. Nisin ZP was administrated during and after the chemotherapy. RESULTS: The patient experienced symptom relief and significant tumor regression following administration of nisin ZP. CONCLUSION: Nisin ZP shows promising potential as an adjunctive therapy for OSCC, offering symptom relief and contributing to tumor size reduction.